Raltegravir (Isentress)

Published November 13, 2007; Updated January 08, 2014
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-01
Selected Reference
11. Hazuda DJ, Miller MD, Nguyen BY, et al, Resistance to the HIV-integrase inhibitor raltegravir: analysis of protocol 005, a phase II study in patients with triple-class resistant HIV-1 infection. In: Program and abstracts of the XVI International HIV Drug Resistance Workshop; June 12-16, 2007; St. Michael, Barbados. Abstract 8.